NCT02706704View on ClinicalTrials.gov

Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
UveitisNon-Infectious Uveitis
Interventions
DRUG

Adalimumab

Trial Locations (1)

Unknown

RECRUITING

American University of Beirut Medical Center, Beirut

All Listed Sponsors
lead

American University of Beirut Medical Center

OTHER

NCT02706704 - Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis | Biotech Hunter | Biotech Hunter